Evidence map›Paper›PMID 34651027›Full record

ArticleFrontiers in cardiovascular medicine2021

Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.

Shen Dai, Fengming Liu, Mi Ren, Zhongnan Qin, Namita Rout, Xiao-Feng Yang, Hong Wang, Stephen Tomlinson, Xuebin Qin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Deficiency of Caspase-1 Attenuates HIV-1-Associated Atherogenesis in Mice.International journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Shen DaiDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States.
Fengming LiuDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States.
Mi RenDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Zhongnan QinDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States.
Namita RoutDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Xiao-Feng YangCenter for Metabolic Disease Research and Cardiovascular Research, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.
Hong WangCenter for Metabolic Disease Research and Cardiovascular Research, Temple University Lewis Katz School of Medicine, Philadelphia, PA, United States.
Stephen TomlinsonDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
Xuebin QinDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA, United States.
Tulane University · USTemple University · USMB Clinical Research and Consulting (United States) · USMedical University of South Carolina · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
BLRD VA IK6 BX005235NIH HHS P51 OD011104
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

animal–mouseatherosclerosiscomplementnatural antibodyoxidization

Identifiers

PMID34651027
PMCPMC8505745
OpenAlexW3204022312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.